Nuvalent, Inc.

NasdaqGS:NUVL 株式レポート

時価総額:US$6.7b

Nuvalent 過去の業績

過去 基準チェック /06

Nuvalentの収益は年平均-48.7%で減少しているが、Biotechs業界はgrowingで19.3%年平均の収益となった。

主要情報

-48.7%

収益成長率

38.5%

EPS成長率

Biotechs 業界の成長17.0%
収益成長率n/a
株主資本利益率-27.2%
ネット・マージンn/a
前回の決算情報30 Jun 2024

最近の業績更新

更新なし

Recent updates

Nuvalent: Promising Data Keeps Validating Pipeline And Platform

Sep 23

Nuvalent: Likely Approvals Coming Up Do Not Justify This Valuation

Sep 17

Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business

Aug 05
Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business

Nuvalent: Making Precise Progress In Its Oncology Pipeline

Jun 24

Nuvalent: NVL-655 Could Bring Blockbuster Potential

Jun 14

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Apr 22
Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024

Feb 26

Is Nuvalent, Inc. (NASDAQ:NUVL) Trading At A 36% Discount?

Jan 07
Is Nuvalent, Inc. (NASDAQ:NUVL) Trading At A 36% Discount?

Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth

Sep 23
Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth

Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Jun 10
Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

We're Interested To See How Nuvalent (NASDAQ:NUVL) Uses Its Cash Hoard To Grow

Feb 24
We're Interested To See How Nuvalent (NASDAQ:NUVL) Uses Its Cash Hoard To Grow

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Sep 13
Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Nuvalent GAAP EPS of -$0.38 beats by $0.03

Aug 10

Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

May 28
Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Oct 29
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

収支内訳

Nuvalent の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGS:NUVL 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 240-17450153
31 Mar 240-14642130
31 Dec 230-12636113
30 Sep 230-11432101
30 Jun 230-1002886
31 Mar 230-892573
31 Dec 220-822264
30 Sep 220-732054
30 Jun 220-661849
31 Mar 220-571543
31 Dec 210-461036
30 Sep 210-36727
30 Jun 210-28422
31 Mar 210-27218
31 Dec 200-15215

質の高い収益: NUVLは現在利益が出ていません。

利益率の向上: NUVLは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: NUVLは利益が出ておらず、過去 5 年間で損失は年間48.7%の割合で増加しています。

成長の加速: NUVLの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: NUVLは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( 16.6% ) と比較することは困難です。


株主資本利益率

高いROE: NUVLは現在利益が出ていないため、自己資本利益率 ( -27.25% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘